Clinical Advances in Treatment Strategies for Obsessive-compulsive Disorder in Adults

키워드

참고문헌 (60)

1. Osland S, "The prevalence of diagnosed obsessive compulsive disorder and associated comorbidities : A population-based Canadian study", Psychiatry Res, 268, pp.137~142 (2018)
2. Kessler RC, "Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication", Arch Gen Psychiatry, 62, pp.617~627 (2005)
3. Bobes J, "Quality of life and disability in patients with obsessive-compulsive disorder", Eur Psychiatry, 16, pp.239~245 (2001)
4. Berrios GE, "A history of clinical psychiatry: The origin and history of psychiatric disorders", pp.573~592 (1995), Athlone
5. Raymond F, "Les obsessions et la psychasthénie", pp.543~ (1903), Felix Alcan
6. Castel PH, "A new history of ourselves, in the shadow of our obsessions and compulsions", Philos Psychiatr Psychol, 21, pp.299~309 (2014)
7. Solomon RL, "Traumatic avoidance learning : The outcomes of several extinction procedures with dogs", J Abnorm Psychol, 48, pp.291~302 (1953)
8. Meyer V, "Modification of expectations in cases with obsessional rituals", Behav Res Ther, 4, pp.273~280 (1966)
9. Goodman WK, "Obsessivecompulsive disorder", Psychiatr Clin North Am, 37, pp.257~267 (2014)
10. Fernández Córdoba E, "Use of monochlorimipramine in psychiatric patients who are resistant to other therapy", Actas Luso Esp Neurol Psiquiatr, 26, pp.119~147 (1967)
11. Vahabzadeh A, "Neurobiology of Brain Disorders", pp.612~620 (2015), Academic
12. American Psychiatric Association, "Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5)" (2013), American Psychiatric Association
13. Mataix-Cols D, "Population-based, multigenerational family clustering study of obsessive-compulsive disorder", JAMA Psychiatry, 70, pp.709~717 (2013)
14. Mahjani B, "Maternal effects as causes of risk for obsessivecompulsive disorder", Biol Psychiatry, 87, pp.1045~1051 (2020)
15. Bandelow B, "World Federation of Societies of Biological Psychiatry(WFSBP)guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders-Version 3. Part II : OCD and PTSD", World J Biol Psychiatry, 24, pp.118~134 (2023)
16. Nezgovorova V, "Optimizing first line treatments for adults with OCD", Compr Psychiatry, 115, pp.152305~ (2022)
17. Hirschtritt ME, "Obsessive-compulsive disorder : Advances in diagnosis and treatment", JAMA, 317, pp.1358~1367 (2017)
18. Stein DJ, "Obsessive-compulsive disorder", Nat Rev Dis Primers, 5, pp.52~ (2019)
19. Del Casale A, "Psychopharmacological treatment of obsessive-compulsive disorder(OCD)", Curr Neuropharmacol, 17, pp.710~736 (2019)
20. 김원, "한국형 강박장애 치료 알고리듬 2007(Ⅰ): 개발과정과 개요", 대한정신약물학회지, 18(5), pp.338~346 (2007), 대한정신약물학회
21. Pallanti S, "Treatment-refractory obsessive-compulsive disorder : Methodological issues, operational definitions and therapeutic lines", Prog Neuropsychopharmacol Biol Psychiatry, 30, pp.400~412 (2006)
22. Skapinakis P, "Pharmacological and psychotherapeutic interventions for management of obsessivecompulsive disorder in adults : A systematic review and network meta-analysis", Lancet Psychiatry, 3, pp.730~739 (2016)
23. Fineberg NA, "Pharmacotherapy of obsessive-compulsive disorder : Evidencebased treatment and beyond", Aust N Z J Psychiatry, 47, pp.121~141 (2013)
24. Erzegovesi S, "Clinical predictors of drug response in obsessive-compulsive disorder", J Clin Psychopharmacol, 21, pp.488~492 (2001)
25. Van Ameringen M, "Pharmacological treatment strategies in obsessive compulsive disorder : A cross-sectional view in nine international OCD centers", J Psychopharmacol, 28, pp.596~602 (2014)
26. Dold M, "Antipsychotic augmentation of serotonin reuptake inhibitors in treatmentresistant obsessive-compulsive disorder : A meta-analysis of double-blind, randomized, placebo-controlled trials", Int J Neuropsychopharmacol, 16, pp.557~574 (2013)
27. Li X, "Risperidone and haloperidol augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder : A crossover study", J Clin Psychiatry, 66, pp.736~743 (2005)
28. Veale D, "Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder : A systematic review and meta-analysis", BMC Psychiatry, 14, pp.317~ (2014)
29. Muscatello MR, "Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment-resistant obsessive-compulsive disorder : A double-blind, placebo-controlled study", J Clin Psychopharmacol, 31, pp.174~179 (2011)
30. Sayyah M, "Effects of aripiprazole augmentation in treatment-resistant obsessive-compulsive disorder(a double blind clinical trial)", Depress Anxiety, 29, pp.850~854 (2012)
31. Leucht S, "Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia : A multiple-treatments meta-analysis", Lancet, 382, pp.951~962 (2013)
32. Albert U, "Role and clinical implications of atypical antipsychotics in anxiety disorders, obsessive-compulsive disorder, traumarelated, and somatic symptom disorders : A systematized review", Int Clin Psychopharmacol, 31, pp.249~258 (2016)
33. Matsunaga H, "A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder", J Clin Psychiatry, 70, pp.863~868 (2009)
34. Hadi F, "Glutamatergic medications as adjunctive therapy for moderate to severe obsessive-compulsive disorder in adults : A systematic review and meta-analysis", BMC Pharmacol Toxicol, 22, pp.69~ (2021)
35. Lee DK, "The potential of N-acetylcysteine for treatment of trichotillomania, excoriation disorder, onychophagia, and onychotillomania : An updated literature review", Int J Environ Res Public Health, 19, pp.6370~ (2022)
36. Sarris J, "N-acetyl cysteine(NAC)augmentation in the treatment of obsessive-compulsive disorder : A phase III, 20-week, doubleblind, randomized, placebo-controlled trial", Prog Neuropsychopharmacol Biol Psychiatry, 117, pp.110550~ (2022)
37. Bandeira ID, "Ketamine in the treatment of obsessive-compulsive disorder : A systematic review", Harv Rev Psychiatry, 30, pp.135~145 (2022)
38. Grassi G, "Investigational and experimental drugs to treat obsessive-compulsive disorder", J Exp Pharmacol, 12, pp.695~706 (2021)
39. Andrade C, "Ondansetron augmentation of serotonin reuptake inhibitors as a treatment strategy in obsessive-compulsive disorder", J Clin Psychiatry, 76, pp.e72~e75 (2015)
40. Hewlett WA, "Clomipramine, clonazepam, and clonidine treatment of obsessive-compulsive disorder", J Clin Psychopharmacol, 12, pp.420~430 (1992)
41. Denys D, "A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder", J Clin Psychopharmacol, 23, pp.568~575 (2003)
42. Grant JE, "Tolcapone in obsessive-compulsive disorder : A randomized double-blind placebo-controlled crossover trial", Int Clin Psychopharmacol, 36, pp.225~229 (2021)
43. Öst LG, "Cognitive behavioral treatments of obsessive-compulsive disorder. A systematic review and meta-analysis of studies published 1993-2014", Clin Psychol Rev, 40, pp.156~169 (2015)
44. Reid JE, "Cognitive behavioural therapy with exposure and response prevention in the treatment of obsessive-compulsive disorder : A systematic review and metaanalysis of randomised controlled trials", Compr Psychiatry, 106, pp.152223~ (2021)
45. Marzano L, "The application of mHealth to mental health : Opportunities and challenges", Lancet Psychiatry, 2, pp.942~948 (2015)
46. Hoppen LM, "Low intensity technology-delivered cognitive behavioral therapy for obsessive-compulsive disorder : A meta-analysis", BMC Psychiatry, 21, pp.322~ (2021)
47. Soondrum T, "The applicability of acceptance and commitment therapy for obsessivecompulsive disorder : A systematic review and meta-analysis", Brain Sci, 12, pp.656~ (2022)
48. Abramowitz JS, "New directions in the cognitive-behavioral treatment of OCD : Theory, research, and practice", Behav Ther, 49, pp.311~322 (2018)
49. Samantaray NN, "Efficacy of inhibitory learning theory-based exposure and response prevention and selective serotonin reuptake inhibitor in obsessive-compulsive disorder management : A treatment comparison", Ind Psychiatry J, 27, pp.53~60 (2018)
50. O’Connor K, "Beyond reasonable doubt: Reasoning processes in obsessive-compulsive disorder and related disorders" (2005), John Wiley & Sons
51. O’Connor K, "Clinician’s handbook for obsessive compulsive disorder: Inference-based therapy" (2012), Wiley-Blackwell
52. Julien D, "The inference-based approach to obsessive-compulsive disorder : A comprehensive review of its etiological model, treatment efficacy, and model of change", J Affect Disord, 202, pp.187~196 (2016)
53. Aardema F, "Evaluation of inference-based cognitive-behavioral therapy for obsessive-compulsive disorder : A multicenter randomized controlled trial with three treatment modalities", Psychother Psychosom, 91, pp.348~359 (2022)
54. Perera MPN, "Repetitive transcranial magnetic stimulation for obsessive-compulsive disorder : A meta-analysis of randomized, sham-controlled trials", Biol Psychiatry Cogn Neurosci Neuroimaging, 6, pp.947~960 (2021)
55. Harmelech T, "Long-term outcomes of a course of deep TMS for treatment-resistant OCD", Brain Stimul, 15, pp.226~228 (2022)
56. Alonso P, "Deep brain stimulation for obsessivecompulsive disorder : A meta-analysis of treatment outcome and predictors of response", PLoS One, 10, pp.e0133591~ (2015)
57. Martinho FP, "Efficacy, effect on mood symptoms, and safety of deep brain stimulation in refractory obsessive-compulsive disorder : A systematic review and metaanalysis", J Clin Psychiatry, 81, pp.19~ (2020)
58. Hageman SB, "Deep brain stimulation versus ablative surgery for treatment-refractory obsessive-compulsive disorder : A meta-analysis", Acta Psychiatr Scand, 143, pp.307~318 (2021)
59. Jung HH, "Bilateral thermal capsulotomy with MR-guided focused ultrasound for patients with treatment-refractory obsessivecompulsive disorder : A proof-of-concept study", Mol Psychiatry, 20, pp.1205~1211 (2015)
60. Zohar J, "Pharmacological treatment of obsessive compulsive disorder : A review", Obsessive Compuls Disord, 4, pp.43~92 (2000)

관련 논문AI추천